Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings)
Glaukos (NYSE:GKOS) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. ...
Source: businessinsider.com
Stay updated with breaking news from Samuel Brodovsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Glaukos (NYSE:GKOS) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. ...
Corrected Transcript 01-May-2024 Glaukos Corp. Q1 2024 Earnings Call ...
The surgical robotics industry saw a major shakeup last year. Here is MassDevice's roundup of companies to watch.
Pain-treatment device company Nevro is letting go of 63 employees, about 5% of its workforce, as part of a restructuring effort.
Today released a solid preliminary earnings update that included projections of up to 20% revenue growth in 2024.